Search Results 11-20 of 15994 for GLP-1 agonist

  1. Tradipitant After GLP-1R Agonist In Healthy, Overweight, or Class I or II Obese Volunteers - Mayo Clinic

    The purpose of this study is to evaluate the effect of tradipitant relative to placebo on proportion of subjects with at least 1 vomiting episode per week ...

  2. Tirzepatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    ... glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide injection is ... It is not safe for one pen to be used for more than one person. Sharing ...

  3. Semaglutide (oral route) - Side effects & dosage - Mayo Clinic

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide is also used together with diet and exercise to help lose weight and keep the ...

  4. Prescription weight-loss drugs - Mayo Clinic

    FDA's concerns with unapproved GLP-1 drugs used for weight loss. ... https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas- ...

  5. Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in Type 1 and Type 2 Diabetes - Mayo Clinic

    Prior use of GLP-1 receptor agonists in the previous year. Active systemic illness or malignancy. Symptomatic macrovascular or microvascular disease. Note ...

  6. Liraglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist. Liraglutide injection is also used together with a reduced-calorie diet and proper ...

  7. Management of obesity within hepatology clinics - Mayo Clinic

    Researchers discuss the role of dietary supplements, glucagon-like peptide 1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and bariatric ...

  8. Why gastroenterologists and hepatologists should be involved in treating obesity - Mayo Clinic

    Meta-analyses suggest that the GLP-1 agents SQ semaglutide and liraglutide perform well in this role. GLP-1 agonists are associated with an increased risk of ...

  9. Diabetes treatment: Medications for type 2 diabetes - Mayo Clinic

    Tirzepatide (Mounjaro), a similar kind of medicine called a dual-acting GLP-1/GIP agonist. Action. Cause the release of insulin as blood sugar levels are ...

  10. Lixisenatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Lixisenatide is used together with diet and exercise to help control your blood sugar. This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist. This ...